Aflibercept vs. dexamethasone implant for recalcitrant diabetic macular edema in pseudophakic eyes - 1-year outcomes from a quazi-randomized study in India.

MLA

Chakraborty, Debdulal, et al. “Aflibercept vs. Dexamethasone Implant for Recalcitrant Diabetic Macular Edema in Pseudophakic Eyes - 1-Year Outcomes from a Quazi-Randomized Study in India.” Indian Journal of Ophthalmology, vol. 72, no. 7, July 2024, pp. 1001–06. EBSCOhost, https://doi.org/10.4103/IJO.IJO_1447_23.

APA

Chakraborty, D., Mondal, S., Sengupta, S., Maiti, A., Boral, S., Das, A., Sinha, T. K., & Nandi, K. (2024). Aflibercept vs. dexamethasone implant for recalcitrant diabetic macular edema in pseudophakic eyes - 1-year outcomes from a quazi-randomized study in India. Indian Journal of Ophthalmology, 72(7), 1001–1006. https://doi.org/10.4103/IJO.IJO_1447_23

Chicago

Chakraborty, Debdulal, Soumen Mondal, Sabyasachi Sengupta, Aniruddha Maiti, Subhendu Boral, Arnab Das, Tushar K Sinha, and Krishnendu Nandi. 2024. “Aflibercept vs. Dexamethasone Implant for Recalcitrant Diabetic Macular Edema in Pseudophakic Eyes - 1-Year Outcomes from a Quazi-Randomized Study in India.” Indian Journal of Ophthalmology 72 (7): 1001–6. doi:10.4103/IJO.IJO_1447_23.